tiprankstipranks
Vera Therapeutics reports Q3 EPS (85c), consensus (66c)
PremiumThe FlyVera Therapeutics reports Q3 EPS (85c), consensus (66c)
16d ago
Vera Therapeutics 7.14M share Secondary priced at $42.00
Premium
The Fly
Vera Therapeutics 7.14M share Secondary priced at $42.00
24d ago
Vera Therapeutics Advances Atacicept with Promising Trial Results
Premium
Company Announcements
Vera Therapeutics Advances Atacicept with Promising Trial Results
26d ago
Vera Therapeutics initiated with an Outperform at Scotiabank
PremiumThe FlyVera Therapeutics initiated with an Outperform at Scotiabank
1M ago
Vera Therapeutics Expands Atacicept Autoimmune Kidney Studies
Premium
Company Announcements
Vera Therapeutics Expands Atacicept Autoimmune Kidney Studies
2M ago
Vera Therapeutics to expand development pipeline for atacicept
Premium
The Fly
Vera Therapeutics to expand development pipeline for atacicept
2M ago
Vera Therapeutics expects cash to fund operations through atacicept approval
PremiumThe FlyVera Therapeutics expects cash to fund operations through atacicept approval
4M ago
Vera Therapeutics reports Q2 EPS (62c), consensus (56c)
Premium
The Fly
Vera Therapeutics reports Q2 EPS (62c), consensus (56c)
4M ago
Vera Therapeutics Names David Johnson as New COO
Premium
Company Announcements
Vera Therapeutics Names David Johnson as New COO
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100